I-105

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameI-105
Drug Alias NameD1/D2 dopamine receptor interfering peptide (CAMH)D1/D2 dopamine receptor interfering peptide (Impel NeuroPharma)I-105
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionDopamine D2 receptor modulatorsDopamine D1 receptor modulators
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorMood Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre For Addiction And Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImpel Pharmaceuticals LLCCentre For Addiction And Mental Health
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepressive Disorder, MajorMood Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A